In this article it was mistakenly stated that Akimitsu Miyauchi is affiliated with both Miyauchi Medical Center, Osaka and Amgen Astellas BioPharma K.K., Tokyo. In fact he is affiliated only with Miyauchi Medical Center; he has no connection with Amgen Astellas.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11657-018-0460-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lipid-lowering Therapy and Coronary Plaque Regression.
J Atheroscler Thromb
November 2024
Department of Cardiovascular Medicine, Shinshu University Hospital.
Lipid-lowering therapy plays a central role in reducing cardiovascular events. Over the past few decades, clinical trials utilizing several imaging techniques have consistently shown that lipid-lowering therapy can reduce the coronary plaque burden and improve plaque composition. Although intravascular ultrasound has been the most extensively used modality to assess plaque burden, other invasive modalities, such as optical coherence tomography and near-infrared spectroscopy, provide relevant data on plaque vulnerability, and computed tomography angiography detects both plaque volume and characteristics non-invasively.
View Article and Find Full Text PDFAssociation between dietary variety status and sarcopenia as defined by the Asian Working Group for Sarcopenia 2019 consensus in older outpatients at a hospital specializing in geriatric medicine: A cross‑sectional study with baseline data of prospective cohort study (JUSTICE‑TOKYO study).
Biomed Rep
August 2024
Department of Cardiology, Juntendo Tokyo Koto Geriatric Medical Center, Shinsuna, Koto, Tokyo 1360075, Japan.
To the best of our knowledge, little is known about the association between dietary variety status and sarcopenia in university-affiliated geriatric hospital in elderly. The present study aimed to investigate, in a multidisciplinary setting, the prevalence of sarcopenia and association between dietary variety status and sarcopenia in older outpatients at Juntendo Tokyo Koto Geriatric Medical Center (Tokyo, Japan). Between October 2020 and December 2021, a cross-sectional study of outpatients aged ≥65 years [458 male (44%) and 584 female (56%); mean age, 78.
View Article and Find Full Text PDFGlobal research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis.
Front Endocrinol (Lausanne)
November 2023
Department of Endocrinology and Metabolism, Institute of Endocrinology, National Health Commission Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Background: Papillary thyroid cancer (PTC) is the most common endocrine malignancy worldwide. The treatment of PTC has attracted extensive attention and discussion from the public and scholars. However, no article has systematically assessed the related literature.
View Article and Find Full Text PDFDiffering effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction.
BMC Cardiovasc Disord
January 2021
Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Article Synopsis
- The study aimed to compare the effects of beta-blockers on long-term clinical outcomes in patients with ischemic heart disease, focusing on those with mid-range ejection fraction (mrEF) and reduced ejection fraction (rEF).
- After analyzing data from 3,508 patients, it was found that beta-blockers did not significantly impact the outcomes for those with mrEF, while they were linked to better outcomes for patients with rEF.
- The research concluded that beta-blockers may be beneficial for rEF patients, but not for mrEF patients in terms of long-term survival and cardiovascular events.
Hic-5 is required for activation of pancreatic stellate cells and development of pancreatic fibrosis in chronic pancreatitis.
Sci Rep
November 2020
Department of Biochemistry, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Accumulated evidence suggests that activated pancreatic stellate cells (PSCs) serve as the main source of the extracellular matrix proteins accumulated under the pathological conditions leading to pancreatic fibrosis in chronic pancreatitis (CP). However, little is known about the mechanisms of PSC activation. PSCs have morphologic and functional similarities to hepatic stellate cells, which are activated by hydrogen peroxide-inducible clone-5 (Hic-5), a TGF-β1-induced protein.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!